Parkinson's Disease Trial, Recruiting NCT06884722 Sponsor: Hospices Civils de Lyon Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06884722
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 30 and 75 years old, of any sex
  • People who are willing and able to give written consent to take part in the study
  • People who are covered by a social security system or equivalent
  • People who have been diagnosed with Parkinson's disease (according to recognised diagnostic criteria) for at least 3 years and are currently receiving a dopaminergic medication (a type of medication commonly used to treat Parkinson's disease) — this applies to patients only
  • Women of childbearing age or post-menopausal women who are using effective contraception — this applies to patients and healthy volunteers in the imaging stage of the study
  • Patients who are already scheduled to have a "dopa test" as part of their usual care — this applies to patients in the imaging stage only
  • People who do not have significant cognitive (thinking or memory) difficulties, as measured by a standard screening test (a score of 26 or above on the MoCA test)
  • Healthy volunteers who do not have a long-term condition associated with disability

Who may not be able to join:

  • People who cannot safely have an MRI scan — for example, those with a pacemaker not approved for use in a 3 Tesla MRI, metal materials inside the skull or eyes, other non-removable metallic objects in the head area, or those who experience severe anxiety in enclosed spaces (claustrophobia) — this applies to patients and healthy volunteers in the imaging stage
  • People who have had a serious head injury involving loss of consciousness lasting more than 30 minutes — this applies to patients and healthy volunteers in the imaging stage
  • People who do not agree to be told if an unexpected abnormality is found on their MRI scan — this applies to patients and healthy volunteers in the imaging stage
  • Patients whose tremors or involuntary movements are severe enough to prevent an MRI scan from being completed — this applies to patients in the imaging stage
  • Healthy volunteers who have already received the maximum amount of compensation allowed under French rules for taking part in research studies
  • Women who are pregnant, in labour, or currently breastfeeding
  • People who are currently detained or imprisoned by a legal or administrative decision
  • People who are currently receiving involuntary psychiatric care
  • People who are living in a health or social care facility for reasons unrelated to research
  • Adults who are under a legal protection order (such as guardianship or curatorship)
  • People who are currently in an exclusion period from another interventional research study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 472 357 222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 July 2025
Est. completion
1 April 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

BOLD signal difference in the brain networks associated with social perception in Parkinson's patients compared with age- and sex-matched healthy volunteers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov